Current Report Filing (8-k)
May 17 2013 - 4:33PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: May 15, 2013
XSUNX, INC.
---------------
(Exact name of registrant as specified in its
charter)
Colorado |
000-29621 |
84-1384159 |
(State of Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer
Identification No.) |
|
|
|
65 Enterprise, Aliso Viejo, CA 92656
------------------------------------
(New address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area
code: (949) 330-8060
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|_| Written communications pursuant to Rule
425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12
under the Exchange Act
(17 CFR 240.14a-12)
|_| Pre-commencement communications pursuant
to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant
to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On
May 15, 2013, XsunX, Inc., a Colorado corporation (the “Company”) issued a press release (the “Press
Release”) announcing that Dr. John R. Tuttle had joined the Company’s Scientific and Business Development Advisory
Board. The Press Release outlined how the Company welcomed Dr. Tuttle’s extensive entrepreneurial background and comprehensive
knowledge of the Cleantech industry.
The Press Release further
provided information related to Dr. Tuttle’s qualifications as follows: Dr. John R. Tuttle brings 30 years of experience in
the semiconductor & photovoltaic industries to XsunX, and for the last several years has focused on assisting with operational
and capital management of early-stage companies in the Cleantech sector. Previously, he was the co-founder, Chief Executive &
Chairman of DayStar Technologies, Inc. where he took the company from 3 employees to an operational organization with world-class
development and pilot production facilities, achieving an over 900% value creation for its IPO shareholders.
From 1986-1997, Dr. Tuttle
held the position of Senior Scientist at NREL where his research guided the fabrication of thin-film CIGS PV devices with multiple
world-record efficiencies. He has authored/co-authored over 70 publications, 14 Patent’s / Patent applications, and conducted
over 100 presentations about technology & business development. Dr. Tuttle holds a Ph.D. in EE from the University of Colorado,
an M.S. from the Colorado School of Mines and a B.S in Applied and Engineering Physics from Cornell University.
A copy of the Press release
is attached hereto as Exhibit 99.1 and is hereby incorporated by reference into this Item 8.01.
Item 9.01 Financial
Statements and Exhibits.
(a) Not
applicable.
(b) Not
applicable.
(c) Not
applicable.
(d) Exhibit
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
XSUNX, INC. |
|
|
|
Date: May 15, 2013 |
By: |
/s/ Tom M. Djokovich |
|
Tom M. Djokovich |
|
Title: CEO/Secretary |
NovAccess Global (QB) (USOTC:XSNX)
Historical Stock Chart
From Jun 2024 to Jul 2024
NovAccess Global (QB) (USOTC:XSNX)
Historical Stock Chart
From Jul 2023 to Jul 2024